glp 1 agonist mechanism of action Frontiers GLP-1: Actions on Beta-cell Mass
Description
Studies suggest that diabetes may be associated with increased rates of eye diseases and conditions, like retinopathy
the apparent high incidence should be interpreted cautiously given the small denominator and high baseline AKI risk in advanced CKD
This suggests that the lifetime costs for comorbidity treatment and health care utilization may also be substantially lower after MBS than with GLP-1 RA treatment
[DOI] [PMC free article] [PubMed] [Google Scholar] 523.Macfarlane W.M., Frayling T.M., Ellard S., Evans J.C., Allen L.I., Bulman M.P
